ImmunoGen Q4 Loss Narrows - Quick Facts

(RTTNews) - ImmunoGen Inc. (IMGN) reported a fourth-quarter net loss of $21.9 million, or $0.26 per share, compared to a net loss of $22.4 million, or $0.29 per share in the year ago quarter.

Total Revenues for the quarter increased to $3.83 million from $2.95 million last year.

Analysts polled by Thomson Reuters expected the company to report a loss of $0.30 per share and revenues of $3.44 million for the quarter. Analysts' estimates typically exclude special items.

For its fiscal year ending June 30, 2014, the company expects its revenues to be between $66 million and $70 million, its expenses to be between $140 million and $144 million, its net loss to be between $72 million and $76 million, its cash used in operations to be between $74 million and $78 million, and its capital expenditures to be between $6 million and $8 million. Analysts expect the company to report revenues of $47.08 million for fiscal 2014.